Danaher Corporation (DHR)
NYSE·Healthcare·Medical - Diagnostics & Research
$199.80
+1.70%
Mkt Cap $134.62B
Analyst Ratings
Buy
16
Hold
4
Sell
0
Price Target (52 analysts)
$230.89
Range $200.00 – $265.00
Implied Upside
+15.6%
Consensus $230.89 vs current $199.80